Go Back   HER2 Support Group Forums > General Cancer News
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

General Cancer News Latest Breast Cancer News from Moreover Technologies

Thread Tools Display Modes
Old 12-23-2019, 11:42 AM   #1
Senior Member
News's Avatar
Join Date: Oct 2007
Posts: 16,979
Sphingotec's new biomarker bio-ADM identifies ICU patients who need immediate organ s

Diagnostics company SphingoTec GmbH today announced a publication in Critical Care1 with data on 2,000 ICU patients demonstrating that sphingotec's proprietary biomarker bio-ADM (Bioactive Adrenomedullin) not only identifies high-risk patients for septic shock at admission but also identifies patients in the general ICU patient population who require immediate life-saving therapeutic intervention.

News is offline   Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

All times are GMT -7. The time now is 03:40 PM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2020, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter